UA81493C2 - Crystal of benzimidazole derivative and process for producing the same - Google Patents

Crystal of benzimidazole derivative and process for producing the same

Info

Publication number
UA81493C2
UA81493C2 UAA200511908A UAA200511908A UA81493C2 UA 81493 C2 UA81493 C2 UA 81493C2 UA A200511908 A UAA200511908 A UA A200511908A UA A200511908 A UAA200511908 A UA A200511908A UA 81493 C2 UA81493 C2 UA 81493C2
Authority
UA
Ukraine
Prior art keywords
crystal
producing
same
benzimidazole derivative
crystals
Prior art date
Application number
UAA200511908A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33447189&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA81493(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of UA81493C2 publication Critical patent/UA81493C2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
UAA200511908A 2003-05-14 2004-05-14 Crystal of benzimidazole derivative and process for producing the same UA81493C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003135567 2003-05-14
PCT/JP2004/006887 WO2004101551A1 (ja) 2003-05-14 2004-05-14 ベンズイミダゾール誘導体の結晶及びその製造方法

Publications (1)

Publication Number Publication Date
UA81493C2 true UA81493C2 (en) 2008-01-10

Family

ID=33447189

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200511908A UA81493C2 (en) 2003-05-14 2004-05-14 Crystal of benzimidazole derivative and process for producing the same

Country Status (25)

Country Link
US (1) US7649008B2 (xx)
EP (1) EP1626048A4 (xx)
JP (1) JPWO2004101551A1 (xx)
KR (1) KR20060011997A (xx)
CN (1) CN1788007A (xx)
AR (1) AR044340A1 (xx)
AU (1) AU2004238708A1 (xx)
BR (1) BRPI0410266A (xx)
CA (1) CA2523978A1 (xx)
CL (1) CL2004001034A1 (xx)
CO (1) CO5660259A2 (xx)
EC (1) ECSP056162A (xx)
IS (1) IS8177A (xx)
MA (1) MA27805A1 (xx)
MX (1) MXPA05011851A (xx)
NO (1) NO20055181L (xx)
NZ (1) NZ542978A (xx)
PE (1) PE20050203A1 (xx)
RU (1) RU2332417C2 (xx)
SA (1) SA04250117B1 (xx)
TN (1) TNSN05288A1 (xx)
TW (1) TW200505911A (xx)
UA (1) UA81493C2 (xx)
WO (1) WO2004101551A1 (xx)
ZA (1) ZA200508640B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2004001034A1 (es) 2003-05-14 2005-03-28 Teijin Pharma Ltd Formas cristalinas de acido 4-(1-((,etilbenzotiofen-3-il)me til)benzimidazol-2-iltio)butanoico; procedimiento de preparacion de las formas cristalinas; composicion farmaceutica; y su uso para el tratamiento de enfermedades inflamatorias, alergicas, r
WO2005018672A1 (ja) * 2003-08-22 2005-03-03 Teijin Pharma Limited キマーゼ阻害剤を有効成分として含有する薬剤
EP1826207A4 (en) * 2004-11-12 2009-05-20 Teijin Pharma Ltd ACID SALT OF A BENZIMIDAZOLE DERIVATIVE AND CRYSTAL THEREOF
JP2016150917A (ja) * 2015-02-17 2016-08-22 株式会社トクヤマ バルサルタンの結晶の製造方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3683760D1 (de) 1986-03-21 1992-03-12 Heumann Pharma Gmbh & Co Kristalline, wasserfreie sigma -form von 2-(4-(2-furoyl-(2-piperazin)-1-yl)-4-amino-6,7-dimethoxychinazolinhydrochlorid und verfahren zu ihrer herstellung.
US5015646A (en) 1987-08-28 1991-05-14 Bristol-Myers Squibb Co. Pharmaceutically useful polymorphic modification of buspirone
CN1048239C (zh) 1994-05-31 2000-01-12 帝人株式会社 萘衍生物
ES2150353B1 (es) 1998-04-15 2001-07-01 Esteve Labor Dr Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos.
US20040010004A1 (en) * 2000-01-17 2004-01-15 Naoki Tsuchiya Benzimidazole derivatives
JP3923255B2 (ja) 1998-07-15 2007-05-30 帝人株式会社 チオベンズイミダゾール誘導体
EP1249450B1 (en) 2000-01-17 2007-10-10 Teijin Pharma Limited Benzimidazole derivatives as human chymase inhibitors
NZ522150A (en) * 2001-02-22 2006-03-31 Teijin Ltd Benzo[b]thiophene derivatives and processes for preparing the same
EP1298130B1 (en) * 2001-05-07 2008-08-13 Teijin Pharma Limited 3-hydroxymethylbenzo b thiophene derivatives and process for their preparation
NZ528291A (en) * 2001-08-24 2007-03-30 Teijin Ltd Drugs containing chymase inhibitor and ace inhibitor as the active ingredients
CL2004001034A1 (es) 2003-05-14 2005-03-28 Teijin Pharma Ltd Formas cristalinas de acido 4-(1-((,etilbenzotiofen-3-il)me til)benzimidazol-2-iltio)butanoico; procedimiento de preparacion de las formas cristalinas; composicion farmaceutica; y su uso para el tratamiento de enfermedades inflamatorias, alergicas, r

Also Published As

Publication number Publication date
NO20055181D0 (no) 2005-11-03
ZA200508640B (en) 2007-02-28
CO5660259A2 (es) 2006-07-31
RU2332417C2 (ru) 2008-08-27
NO20055181L (no) 2006-01-24
PE20050203A1 (es) 2005-03-26
MA27805A1 (fr) 2006-03-01
TW200505911A (en) 2005-02-16
RU2005138868A (ru) 2006-07-10
US20060293375A1 (en) 2006-12-28
KR20060011997A (ko) 2006-02-06
EP1626048A1 (en) 2006-02-15
CA2523978A1 (en) 2004-11-25
JPWO2004101551A1 (ja) 2006-07-13
ECSP056162A (es) 2006-04-19
CN1788007A (zh) 2006-06-14
US7649008B2 (en) 2010-01-19
AU2004238708A1 (en) 2004-11-25
SA04250117B1 (ar) 2009-09-02
TNSN05288A1 (en) 2007-07-10
WO2004101551A1 (ja) 2004-11-25
NZ542978A (en) 2009-04-30
IS8177A (is) 2005-12-13
CL2004001034A1 (es) 2005-03-28
AR044340A1 (es) 2005-09-07
MXPA05011851A (es) 2006-02-17
BRPI0410266A (pt) 2006-05-16
EP1626048A4 (en) 2008-11-12

Similar Documents

Publication Publication Date Title
UA89787C2 (ru) Фторгликозидные производные пиразолов, лекарственное средство, которое содержит их, и их применение
WO2007120647A3 (en) Compositions useful as inhibitors of voltage-gated sodium channels
NO20071617L (no) Indozolonderivater som 11B-HSD1-inhibitorer
NZ592897A (en) Crystals of laquinimod sodium, and process for the manufacture thereof
JO2282B1 (en) Oxazole derivatives
MY147994A (en) Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors
JO2353B1 (en) New derivatives of mixed-ring fluoroglycosides and drugs containing these compounds and their use
MX2007010532A (es) Derivados de amida de acido 1-sulfonil-piperidina-3-carboxilico como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa para el tratamiento de diabetes mellitus tipo ii.
RS70904A (xx) Postupak za dobijanje indolinona
NO20062599L (no) Fremgangsmate for syntese av perindopril og farmasoytisk akseptable salter derav
MX2007011698A (es) Derivados de oxindol sustituido, medicamentos que contienen dichos derivados y uso de los mismos.
NO20083708L (no) 4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer
IL183636A0 (en) Quinoline derivative, use and production thereof, and drug containing the same
NO20055257L (no) Ny fremgangsmate for syntesen av s-indolin-2-karboksylsyre og anvendelse derav i syntesen av perindopril
GB0314967D0 (en) Piperazine derivatives
WO2003106450A8 (de) Phenylaminopyrimidine und ihre verwendung als rho-kinase inhibitoren
DK1513800T3 (da) Benzoylureido-kanelsyrederivater, fremgangsmåde til deres anvendelse
TW200621703A (en) Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
TNSN05288A1 (en) Crystal of benzimidazole derivative and process for producing the same
MXPA05010020A (es) Derivados de oxamida.
SE0302756D0 (sv) Novel Compounds
IL166057A0 (en) Urea-substituted and urethane-substituted acylureas methods for the production thereof and their useas medicaments
MY136938A (en) New process for the synthesis of perindopril and its pharmaceutically acceptable salts
MY139159A (en) Method for synthesis of perindopril and its pharmaceutically acceptable salts
MY139228A (en) Imidazolinylmethyl aralkylsulfonamides